⏳ Fetching live dividend data...
Home › Calculator › IMMPF Dividend Calculator 2026
ImmuPharma plc · OTC
Price: $0.09 · Annual div: $3.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IMMPF → $39660887342279.16M in 10 years · $3,214,010,319,471,568,400.00/month
ImmuPharma plc, established in London, United Kingdom, in 1999, is a biopharmaceutical company dedicated to discovering and advancing peptide-based therapeutics. These treatments are focused on tackling conditions related to autoimmunity, inflammation, and various infections. The company's primary drug candidate, Lupuzor, an autophagy immunomodulator, is presently in Phase III clinical trials for the management of lupus, a chronic autoimmune inflammatory disorder. Additional product developments include BioAMB, a peptide-based medication for fungal infections, particularly those caused by the aspergillus family, and BioCin, a peptide-derived antibacterial agent designated for high medical need and as a last-resort treatment option. ImmuPharma also maintains a partnership with the Centre National de la Recherche Scientifique (CNRS) to develop a peptide technology platform aimed at diabetes, specifically involving GLP-1 agonists and glucagon antagonists for both Type I and Type II diabetes. Furthermore, the company has a licensing and development agreement in place with Avion Pharmaceuticals LLC.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IMMPF position with:
Real after-tax yield depends on where you live and how you hold IMMPF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3529.41% | 3526.61% | $352,941 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3000.00% | 2997.20% | $300,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2823.53% | 2820.73% | $282,353 / yr |
| 🇬🇧 UK ISA | 0% | 3529.41% | 3526.61% | $352,941 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3220.59% | 3217.79% | $322,059 / yr |
| 🇨🇦 TFSA | 0% | 3529.41% | 3526.61% | $352,941 / yr |
| 🇨🇦 CA Taxable | 25% | 2647.06% | 2644.26% | $264,706 / yr |
| 🇦🇺 Super (pension) | 15% | 3000.00% | 2997.20% | $300,000 / yr |
| 🇦🇺 AU Taxable | 30% | 2470.59% | 2467.79% | $247,059 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2598.53% | 2595.73% | $259,853 / yr |
| 🇫🇷 FR Taxable | 30% | 2470.59% | 2467.79% | $247,059 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $3.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IMMPF pays quarterly — 4 times per year. Next ex-div: TBD.
How IMMPF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IMMPF sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IMMPF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ImmuPharma plc (IMMPF) is a healthcare stock currently trading at $0.09 with a dividend yield of 3529.41%. The company pays an annual dividend of $3.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →